Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Colorcon
Moodys
Julphar
US Department of Justice
AstraZeneca

Generated: September 18, 2019

DrugPatentWatch Database Preview

Patent: 8,129,588

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,129,588
Title:Regulatory sequences for expressing gene products in plant reproductive tissue
Abstract: Expression cassettes causing specific regulatory control of transgene expression in plants, wherein the expression cassettes include regulatory sequences from the MADS gene family for expression of recombinant gene products in the reproductive tissue of plants for the purpose of generating abiotic stress tolerant plants.
Inventor(s): Nuccio; Michael L. (Research Triangle Park, NC), Lagrimini; L. Mark (Apex, NC), Meghji; Moez (Bloomington, IL)
Assignee: Syngenta Participations AG (Basel, CH)
Application Number:11/109,594
Patent Claims:see list of patent claims

Details for Patent 8,129,588

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Try a Free Trial Syngenta Participations AG (Basel, CH) 2037-11-08 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Try a Free Trial Syngenta Participations AG (Basel, CH) 2037-11-08 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Try a Free Trial Syngenta Participations AG (Basel, CH) 2037-11-08 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Queensland Health
Boehringer Ingelheim
McKinsey
Fish and Richardson
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.